Calidi Biotherapeutics, Inc. (CLDWW)

Import this data to Google Sheets with:

=jivedata("CLDWW","financials")

Full statements spill as a table. For one cell: =jivedata("CLDWW","Revenue") or =jivedata("CLDWW","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Calidi Biotherapeutics, Inc.

CLDWW • CIK 0001855485

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-29,200	$-22,195	$-20,048	$-17,491
Income Tax Expense (Benefit)	$16	$14	$15	$17
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	$-22,209	$-20,063	$-17,508
Net Income (Loss) Attributable to Noncontrolling Interest	—	$-66	$-157	$-157
Net Income (Loss) Attributable to Parent	$-29,216	$-22,143	$-19,906	$-17,473
Net Income (Loss) Available to Common Stockholders, Basic	—	$-23,814	$-25,579	$-23,455
Weighted Average Number of Shares Outstanding, Basic	16,887,000	8,005,000	4,302	1,033,733
Research and Development Expense	$13,008	$8,878	$9,737	$9,864
Selling, General and Administrative Expense	$15,984	$12,898	$10,503	$7,987
Operating Expenses	$28,992	$21,776	$20,240	$17,851
Operating Income (Loss)	$-28,992	$-21,776	$-20,240	$-17,851
Gain on Sale of Investments	—	—	$244	$244
Other Nonoperating Income (Expense)	$-51	$9	$103	$239
Nonoperating Income (Expense)	$-208	$-419	$192	$360

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Assets	$10,019	$14,182	$8,857	$7,204
Liabilities	$18,254	$12,214	$5,098	$4,071
Cash	$1,949	$9,591	$5,600	$4,071
Prepaid Expense and Other Assets, Current	$2,354	$636	$656	$1,357
Assets, Current	$4,303	$10,227	$6,256	$5,428
Property, Plant and Equipment, Net	$1,270	$869	$781	$775
Operating Lease, Right-of-Use Asset	$4,073	$2,934	$1,682	$992
Other Assets, Noncurrent	$143	$152	$138	$9
Loans Payable, Current	$1,000	—	—	$1,000
Finance Lease, Liability, Current	$81	$66	$111	$167
Operating Lease, Liability, Current	$1,035	$1,204	$1,405	$1,009
Liabilities, Current	$10,232	$9,496	$3,935	$3,237
Operating Lease, Liability, Noncurrent	$3,037	$1,845	$277	$5
Finance Lease, Liability, Noncurrent	$216	$145	$171	$161
Common Stock, Value, Issued	$4	$2	$1	$1
Additional Paid in Capital	$91,380	$123,275	$145,392	$153,048
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-47	$-28	$-13	$-26
Retained Earnings (Accumulated Deficit)	$-99,572	$-121,715	$-141,621	$-149,889
Stockholders' Equity Attributable to Parent	$-8,235	$1,534	$3,759	$3,133
Stockholders' Equity Attributable to Noncontrolling Interest	—	$434	$434	$280
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	—	$1,968	$3,759	$3,133
Common Stock, Shares Authorized	330,000,000	330,000,000	330,000,000	330,000,000
Common Stock, Shares, Issued	35,522,230	20,760,214	7,216,994	2,082,648
Operating Lease, Liability	$4,072	$3,049	$1,682	$1,014
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseBeforeAccumulatedDepreciation	$607	$588	$779	$906
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	$251	$333	$463	$521
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAfterAccumulatedDepreciation	$356	$255	$316	$385
Finance Lease, Liability	$297	$211	$282	$328

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	$-22,209	$-20,063	$-17,508
Net Cash Provided by (Used in) Operating Activities	$-26,983	$-19,694	$-21,293	$-17,751
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	$-13	$14	$-2
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	—	$7,642	$-3,990	$-1,089
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,167	$9,809	$5,819	$1,890
Depreciation, Depletion and Amortization, Nonproduction	—	—	$1,651	$1,714
Payments to Acquire Machinery and Equipment	$585	$16	$120	$94
Amortization of Debt Discount (Premium)	$432	$45	$45	$45
Payments to Acquire Investments	—	—	$50	$50
Share-based Payment Arrangement, Noncash Expense	$4,809	$2,957	$2,108	$1,367
Net Cash Provided by (Used in) Investing Activities	$-478	$-16	$-170	$-144
Gain on Sale of Investments	—	—	$244	$244
Proceeds from Issuance Initial Public Offering	—	—	$3,268	$2,477
Proceeds from Warrant Exercises	—	$2	$5	$12
Repayments of Debt and Lease Obligation	$101	$82	$90	$147
Repayments of Notes Payable	$1,000	$1,000	$200	$200
Payments of Financing Costs	$2,156	$1,554	$846	$754
Repayments of Related Party Debt	—	—	$2,000	$2,000
Proceeds from Convertible Debt	—	$3,000	$3,000	$3,000
Proceeds from Related Party Debt	$2,550	—	$200	$200
Proceeds from Issuance of Debt	—	$600	$600	$600
Proceeds from Issuance of Warrants	—	—	$4,803	$4,803
Net Cash Provided by (Used in) Financing Activities	$29,044	$27,365	$17,459	$16,808
Interest Paid, Excluding Capitalized Interest, Operating Activities	$404	$140	$1,265	$535
Increase (Decrease) in Prepaid Expense and Other Assets	$2,219	$-1,801	$42	$213
Increase (Decrease) in Accounts Payable	$-6,170	$-628	$-1,328	$-289
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$1,275	$-1,854	$-1,993	$-1,277
IncreaseDecreaseInOperatingLeaseLiability	$-628	$-1,017	$-1,380	$-1,283

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CLDWW","financials")

Full statements spill as a table. For one cell: =jivedata("CLDWW","Revenue") or =jivedata("CLDWW","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.